203Indexed trials
canonical disease area
Schizophrenia / Psychosis
Intelligence
Schizophrenia / Psychosis intelligence: 203 indexed trials, 32 recruiting studies, 145 sponsors across 57 countries.
32Recruiting
145Sponsors
57Countries
Leading sponsors
Sumitomo Pharma America, Inc.50 recruiting
Boehringer Ingelheim50 recruiting
King's College London41 recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.40 recruiting
University of North Carolina, Chapel Hill40 recruiting
New York State Psychiatric Institute40 recruiting
AstraZeneca30 recruiting
Eli Lilly and Company31 recruiting
Shanghai Mental Health Center32 recruiting
National Institute of Mental Health (NIMH)30 recruiting
Johns Hopkins University30 recruiting
Rovi Pharmaceuticals Laboratories30 recruiting
Geographic activity
United States100trials
France23trials
Germany15trials
Spain14trials
Taiwan14trials
United Kingdom13trials
China12trials
Canada11trials
Ukraine10trials
Russia9trials
Japan8trials
Hungary8trials
Leading interventions
Risperidone6trials
risperidone6trials
Lurasidone5trials
Aripiprazole5trials
Olanzapine4trials
olanzapine4trials
Iclepertin4trials
aripiprazole3trials
Treatment as Usual3trials
Placebo patch2trials
Quetiapine2trials
Risperidone ISM® 100 mg2trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.